Variable/cohort | CH-B | CH-C | NAFLD | ALD | Controls |
Prevalence, % | 0.36±0.1 | 1.44±0.22 | 5.5±0.3 | 1.38±0.18 | 81.49±0.60 |
Age, years | 43.1±2.9 | 40.8±1.1 | 42.7±0.7 | 41.6±1.5 | 44.4±0.4 |
Gender, % male | 65.2±8.8 | 66.0±5.0 | 53.2±2.8 | 61.5±6.1 | 45.7±0.6 |
White, % | 47.6±10.0 | 60.9±5.7 | 70.9±2.7 | 72.0±3.6 | 77.1±1.2 |
Smoking, % | 22.7±6.7 | 64.0±5.3 | 20.8±2.2 | 49.0±5.3 | 26.6±0.8 |
Type 2 diabetes, % | 7.0±4.8 | 9.2±2.7 | 11.8±1.2 | 7.4±2.4 | 5.5±0.3 |
Insulin resistance, % | 22.7±6.4 | 37.4±3.2 | 47.5±3.1 | 33.7±5.1 | 22.5±0.9 |
Metabolic syndrome, % | 9.8±4.2 | 19.8±3.8 | 44.8±2.2 | 32.4±5.2 | 25.8±0.8 |
Hypercholesterolaemia, % | 57.1±8.8 | 48.8±6.1 | 75.9±1.6 | 64.5±6.0 | 68.6±0.9 |
Hypertension, % | 10.1±3.9 | 17.8±2.6 | 30.9±2.4 | 36.5±5.7 | 22.2±0.8 |
Obesity, % | 16.1±5.6 | 31.0±4.1 | 54.7±2.6 | 44.5±5.9 | 38.0±0.8 |
ALD, alcoholic liver disease; CH-B, chronic hepatitis B; CH-C, chronic hepatitis C; NAFLD, non-alcoholic fatty liver disease.